Status:
UNKNOWN
Low Dose Statins, Ezetimibe and Nutraceuticals
Lead Sponsor:
University of Roma La Sapienza
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
It remains unknown if the association between moderate to low intensity statin therapy and ezetimibe and nutraceuticals might have a therapeutic role in high-intensity statin intolerant patients
Detailed Description
The aim of this study will be to evaluate whether the association between statin and exetimibe vs statin + ezetimibe + nutraceuticals can lead to higher percentage of LDL target achievement
Eligibility Criteria
Inclusion
- Patients with angiographically assessed diagnosis of coronary artery disease
Exclusion
- None
Key Trial Info
Start Date :
October 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03277079
Start Date
October 1 2017
End Date
March 31 2018
Last Update
September 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sapienza University
Rome, Italy, 00161